Pharmaceutical manufacturing

FILE - This Feb. 6, 2015, file photo shows a measles, mumps and rubella vaccine on a countertop at a pediatrics clinic in Greenbrae, Calif. Hundreds of opponents of mandatory vaccines are opposing a California proposal to give state public health officials instead of local doctors the power to decide which children can skip their shots before attending school. They plan to pack the first legislative hearing Wednesday, April 24, 2019 on a bill that proponents say would stem bogus exemptions granted in many cases by doctors who are paid to excuse students from vaccinations. Supporters say pockets of unvaccinated students help to spread measles. (AP Photo/Eric Risberg, File)
April 24, 2019 - 3:31 pm
SACRAMENTO, Calif. (AP) — Hundreds of critics of mandatory vaccines were in Sacramento Wednesday opposing a California proposal to give state public health officials instead of local doctors the power to decide which children can skip their shots before attending school. They packed the first...
Read More
FILE - In this Oct. 30, 2009 file photo, a mother holds her baby receiving a new malaria vaccine as part of a trial at the Walter Reed Project Research Center in Kombewa in Western Kenya. The World Health Organization said Tuesday April 23, 2019, that Malawi has become the first country to introduce a pilot program vaccinating children against malaria using the only licensed vaccine to protect against the mosquito-spread disease. Although the vaccine only protects about one third of children who are immunized, those who get the shot are likely to have less severe cases of malaria. (AP Photo/Karel Prinsloo, File)
April 23, 2019 - 12:52 pm
LONDON (AP) — The World Health Organization says Malawi has become the first country to begin immunizing children against malaria, using the only licensed vaccine to protect against the mosquito-spread disease. Although the vaccine only protects about one-third of children who are immunized, those...
Read More
FILE - This Friday, Oct. 10, 2008, file photo illustration shows Johnson & Johnson products, in Philadelphia. Johnson & Johnson is topping profit and revenue expectations for the first quarter partially on strong sales of its psoriasis treatment, Stelara. The New Brunswick, N.J., company on Tuesday, April 16, 2019 posted profit of $3.75 billion, or $1.39 per share. Earnings, adjusted for amortization costs and research and development costs, were $2.10 per share, or 7 cents better that Wall Street expected, according to a survey by Zacks Investment Research. (AP Photo/Matt Rourke, File)
April 16, 2019 - 5:04 am
Lower sales overseas and higher costs for research and litigation pushed Johnson & Johnson's first-quarter profit down 14%, but the health care giant still beat profit and revenue expectations. The maker of Tylenol and psoriasis drug Stelara on Tuesday said unfavorable currency exchange rates...
Read More
Prime Therapeutics Senior Vice President, General Counsel, and Interim President and Chief Executive Officer Mike Kolar, right, testifies before the Senate Finance Committee on Capitol Hill in Washington, Tuesday, April 9, 2019, during a hearing to explore the high cost of prescription drugs. He is joined at the table by, from left, Cigna Corporation Executive Vice President and Chief Clinical Officer Steve Miller, CVS Caremark President and CVS Health Executive Vice President Derica Rice, Humana Healthcare Services Segment President William Fleming and OptumRx Chief Executive Officer John Prince. (AP Photo/Susan Walsh)
April 09, 2019 - 11:29 am
Patient bills, competition and secrecy shared the spotlight Tuesday as pharmacy benefit managers testified before Congress about prescription drug prices. Members of a Senate Finance Committee investigating drug costs pushed the benefit managers to explain why they can't do more to control prices...
Read More
April 03, 2019 - 3:57 pm
LITTLE ROCK, Ark. (AP) — Arkansas lawmakers sent the governor legislation Wednesday to expand the secrecy surrounding the source of the state's lethal injection drugs, over the objections of media organizations, pharmaceutical companies and death penalty opponents. The House voted 71-16 to approve...
Read More
March 19, 2019 - 4:06 pm
TRENTON, N.J. (AP) — The U.S. Food and Drug Administration has approved the first drug specifically developed for severe depression after childbirth. The agency on Tuesday approved Sage Therapeutics' Zulresso, an IV drug given over 2 ½ days. Sage said Zulresso will cost $34,000 without insurance,...
Read More
In this June 15, 2018 photo, pharmaceuticals are seen in North Andover, Mass. As Congress and the Trump administration aim to curb spiraling drug costs, outside groups like the Alliance for Patient Access are raising their voices as they seek to sway the outcome. But not all of these organizations are clear about who they actually represent. Their names can obscure the source of the message and they’re cagey about where all of their money comes from. (AP Photo/Elise Amendola)
March 18, 2019 - 4:09 am
WASHINGTON (AP) — As ominous music plays in the background, the narrator of a radio ad echoes objections from drugmakers by warning that a Trump administration proposal to apply international pricing to certain Medicare drugs would be a nightmare for seniors. The one-minute spot is the handiwork of...
Read More
March 12, 2019 - 3:58 am
MINNETONKA, Minn. (AP) — The nation's largest health insurer is expanding a program that passes rebates from drugmakers directly to the people that use their medications. Beginning next year, all employer-sponsored health care plans that use UnitedHealthcare must give point-of-sale discounts...
Read More
FILE- This April 26, 2017, file photo shows the Eli Lilly and Co. corporate headquarters in Indianapolis. Eli Lilly is offering a half-price version of its top-selling insulin Humalog as drugmakers face growing pressure to control prices. The drugmaker says it will introduce a version of the diabetes treatment called Insulin Lispro with a list price 50 percent lower than its current rate, about $275 per vial. (AP Photo/Darron Cummings, File)
March 04, 2019 - 11:32 am
INDIANAPOLIS (AP) — Eli Lilly is offering a half-price version of a top-selling insulin to ease the financial strain imposed on some patients, but an advocacy group says much bigger changes are needed. The drugmaker said Monday it will introduce a version of the diabetes treatment Humalog that will...
Read More
February 27, 2019 - 1:57 am
COPENHAGEN, Denmark (AP) — Volatility in stock markets last year pushed Norway's sovereign wealth fund, the world's largest of its kind, to report a loss of 485 billion kroner ($56.4 billion) for 2018. Fund manager Norges Bank Investment Management says the fund's worst-performing investments in...
Read More

Pages